Tech Company Financing Transactions

QuatRx Pharmaceuticals Funding Round

On 5/22/2007, QuatRx Pharmaceuticals secured $44 million in Series E funding from Venrock, Biomedical Investments and Frazier Healthcare Partners.

Transaction Overview

Announced On
5/22/2007
Transaction Type
Debt
Venture Equity
Amount
$44,000,000
Round
Series E
Proceeds Purpose
The new round of funding will be used primarily to complete ongoing Phase 3 and Phase 2 clinical studies of QuatRx's two endocrine programs, Ophena(TM) and fispemifene, and Phase 1 clinical studies with its lipid-lowering compound, QRX-431.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
777 East Eisenhower Pkwy. 100
Ann Arbor, MI 48108
USA
Email Address
Overview
QuatRx Pharmaceuticals Company is a pharmaceutical company focused on discovering, licensing, developing and commercializing compounds in the endocrine, metabolic and cardiovascular therapeutic areas.
Profile
QuatRx Pharmaceuticals LinkedIn Company Profile
Social Media
QuatRx Pharmaceuticals Company Twitter Account
Company News
QuatRx Pharmaceuticals News
Facebook
QuatRx Pharmaceuticals on Facebook
YouTube
QuatRx Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Robert Zerbe
  Robert Zerbe LinkedIn Profile  Robert Zerbe Twitter Account  Robert Zerbe News  Robert Zerbe on Facebook
Chief Financial Officer
Gary Onn
  Gary Onn LinkedIn Profile  Gary Onn Twitter Account  Gary Onn News  Gary Onn on Facebook
Chief Operating Officer
Christopher Nicholas
  Christopher Nicholas LinkedIn Profile  Christopher Nicholas Twitter Account  Christopher Nicholas News  Christopher Nicholas on Facebook
Chief Scientific Officer
Stuart Dombey
  Stuart Dombey LinkedIn Profile  Stuart Dombey Twitter Account  Stuart Dombey News  Stuart Dombey on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/22/2007: SnapLogic venture capital transaction
Next: 5/23/2007: Cerulean Pharma venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC investment data records on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary